Company Filing History:
1 out of 45 
1 out of 822 
Years Active: 2024
Title: The Innovations of Hideyo Hirai
Introduction
Hideyo Hirai is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for therapeutic and diagnostic applications in medicine.
Latest Patents
Hirai holds a patent for an anti-human CCR1 monoclonal antibody. This monoclonal antibody binds to the human CC chemokine receptor 1 (CCR1) and inhibits its activation. The invention includes an antibody fragment, a hybridoma producing the antibody, and methods for producing the antibody or its fragment. Additionally, it encompasses a therapeutic agent and a diagnostic agent that utilize the antibody or its fragment for treating and diagnosing CCR1-related diseases.
Career Highlights
Throughout his career, Hideyo Hirai has worked with prominent organizations such as Kyowa Kirin Co., Ltd. and Kyoto University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Hirai has collaborated with notable colleagues, including Masayuki Kai and Shinya Ogawa. These partnerships have further enriched his research endeavors and innovations.
Conclusion
Hideyo Hirai's contributions to the field of monoclonal antibodies highlight his role as an influential inventor in biotechnology. His patent for the anti-human CCR1 monoclonal antibody showcases the potential for advancements in medical treatments and diagnostics.